| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +5.19% | -0.35% | +5.54% | +5.54% | — |
| 14d | 1 | +0.00% | +8.31% | +0.04% | +8.26% | +8.26% | — |
| 30d | 1 | +0.00% | +5.59% | -1.43% | +7.03% | +7.03% | — |
| 60d | 1 | +100.00% | -5.24% | -3.02% | -2.22% | -2.22% | — |
| 90d | 1 | +100.00% | -1.40% | +1.45% | -2.85% | -2.85% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| IONS IONIS PHARMACEUTICALS INC | SALE EVP, Chief Development Officer | 21,000 | — | — | 0 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASE EVP, Chief Development Officer | 19,895 | $56.78 | $1.13M | 83,304 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE EVP, Chief Development Officer | 19,895 | — | — | 0 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 19,842 | $74.05 | $1.47M | 22,458 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 41,004 | $73.09 | $3.00M | 42,300 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASE EVP, Chief Development Officer | 7,951 | $60.89 | $484.1K | 30,409 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASE EVP, Chief Development Officer | 12,000 | $32.60 | $391.2K | 63,409 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE EVP, Chief Development Officer | 7,951 | — | — | 21,000 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE EVP, Chief Development Officer | 12,000 | — | — | 0 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASE EVP, Chief Development Officer | 21,000 | $60.89 | $1.28M | 51,409 | Jun 12, 2026 | Jun 16, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE EVP, Chief Development Officer | 4,141 | $75.66 | $313.3K | 14,718 | Jan 16, 2026 | Jan 20, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 11,250 | — | — | 45,730 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASE EVP, Chief Development Officer | 11,119 | — | — | 18,859 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | SALE EVP, Chief Development Officer | 11,119 | — | — | 20,830 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 13,650 | — | — | 34,480 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 9,100 | — | — | 9,100 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| IONS IONIS PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 7,500 | — | — | 16,600 | Jan 2, 2026 | Jan 20, 2026 ↗ | View → |